Drug intelligence / Profile preview

shugan granules

Development stage
Unknown
Lead developer
Kunming Chinese Medicine Factory
Administration
Oral
01

Overview

Shugan Granules is a Traditional Chinese Medicine (TCM) product developed by Kunming Chinese Medicine Factory Co., Ltd. It is formulated to "soothe the liver and regulate qi," addressing symptoms associated with liver depression and qi stagnation. Its primary clinical indication is breast hyperplasia (fibrocystic breast changes), where it is used to alleviate breast pain and reduce the size of nodules. The granules are a multi-herb combination including extracts from *Bupleurum chinense*, *Paeonia lactiflora*, and *Cyperus rotundus*. It has been evaluated in Phase II clinical trials in China for breast hyperplasia and has also been investigated for its efficacy in treating perimenopausal syndrome as part of syndrome-differentiated herbal therapy.

Brand names
Shugan Granules
Other names
Shugan Keli舒肝颗粒
02

Targets

CASP9 (Caspase-9)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP8 (Caspase-8)CASP3 (Caspase-3)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on shugan granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shugan granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call